Reports of sleep disorders were typically characterized as insomnia and occurred in 8.1% and 11% of patients treated with QSYMIA 7.5 mg/46 mg and 15 mg/92 mg, respectively, compared to 5.8% of patients treated with placebo
That leaves a lot of people without coverage for a medication they medically qualify for: the Peterson-KFF Health System Tracker estimates that roughly 34% of non-elderly adults with employer-sponsored insurance have a BMI that would make them eligible for a GLP-1
Whether researchers focus on metabolism, cellular pathways, or biochemical modeling, our materials are built to support every phase of scientific inquiry
But more than a year after Empower said they would take steps to ensure the quality of their ingredients, FDA investigators again found Empower was using ingredients labeled not for drug use to make injectable products, according to records from a December 2023 inspection
They cut across all three